Jan Decloedt

728 total citations
15 papers, 468 citations indexed

About

Jan Decloedt is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Jan Decloedt has authored 15 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Jan Decloedt's work include Ovarian cancer diagnosis and treatment (6 papers), Uterine Myomas and Treatments (4 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). Jan Decloedt is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Uterine Myomas and Treatments (4 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). Jan Decloedt collaborates with scholars based in Belgium, Netherlands and Switzerland. Jan Decloedt's co-authors include Ignace Vergote, Wiebren Tjalma, M. Van Gramberen, Ivo De Wever, Peter van Dam, Peter A. van Dam, Patrick Neven, David Fenton, Sandrina Lambrechts and Patrick Berteloot and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jan Decloedt

15 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Decloedt Belgium	8	382	316	225	63	63	15	468
Marianne J. Rutten Netherlands	10	279 0.7×	229 0.7×	168 0.7×	36 0.6×	41 0.7×	12	403
Meghna Datta United States	6	245 0.6×	72 0.2×	247 1.1×	15 0.2×	43 0.7×	13	366
F. Mayer France	12	201 0.5×	207 0.7×	72 0.3×	58 0.9×	131 2.1×	33	380
Giulia Borghese Italy	12	188 0.5×	88 0.3×	200 0.9×	19 0.3×	54 0.9×	31	342
Fernando Lapuente Spain	9	140 0.4×	144 0.5×	182 0.8×	27 0.4×	72 1.1×	14	318
Kyoko Nishikimi Japan	11	161 0.4×	146 0.5×	86 0.4×	37 0.6×	53 0.8×	46	290
Maria Gabriella Ferrandina Italy	3	240 0.6×	160 0.5×	119 0.5×	31 0.5×	56 0.9×	9	270
Giorgia Dinoi Italy	10	135 0.4×	56 0.2×	215 1.0×	22 0.3×	59 0.9×	22	303
Mehmet Gökçü Türkiye	10	141 0.4×	145 0.5×	123 0.5×	35 0.6×	44 0.7×	53	318
John McDonald United States	8	227 0.6×	88 0.3×	127 0.6×	13 0.2×	32 0.5×	9	303

Countries citing papers authored by Jan Decloedt

Since Specialization

Citations

This map shows the geographic impact of Jan Decloedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Decloedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Decloedt more than expected).

Fields of papers citing papers by Jan Decloedt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Decloedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Decloedt. The network helps show where Jan Decloedt may publish in the future.

Co-authorship network of co-authors of Jan Decloedt

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Decloedt. A scholar is included among the top collaborators of Jan Decloedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Decloedt. Jan Decloedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Cardoen, Brecht, et al.. (2020). Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients. BMJ Open. 10(7). e035389–e035389. 7 indexed citations

2.

Forget, Patrice, Gauthier Bouche, François P. Duhoux, et al.. (2019). Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial. PLoS ONE. 14(12). e0225748–e0225748. 17 indexed citations

3.

Jongen, Lynn, Giuseppe Floris, Hans Wildiers, et al.. (2019). The prognostic role of the androgen receptor in patients with triple-negative early breast cancers and primary surgery.. Journal of Clinical Oncology. 37(15_suppl). e12042–e12042. 1 indexed citations

4.

Lintermans, Anneleen, Annouschka Laenen, Diether Lambrechts, et al.. (2016). Abstract P3-07-46: CYPTAM-BRUT 3: Endometrial thickness cannot be used as a marker for tamoxifen metabolization in postmenopausal breast cancer patients. Cancer Research. 76(4_Supplement). P3–7. 2 indexed citations

5.

Lintermans, Anneleen, Lynn Jongen, Diether Lambrechts, et al.. (2016). Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting.. Journal of Clinical Oncology. 34(15_suppl). 523–523. 3 indexed citations

6.

Lambrechts, Sandrina, Jan Decloedt, & Patrick Neven. (2011). Breast cancer prevention: lifestyle changes and chemoprevention.. PubMed. 66(4). 283–92. 16 indexed citations

7.

Amant, Frédéric, Thomas Tousseyn, Lieve Coenegrachts, et al.. (2011). Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype.. PubMed. 31(6). 2367–71. 16 indexed citations

8.

Vergote, Ignace, Ivo De Wever, Wiebren Tjalma, et al.. (2000). Interval debulking surgery: An alternative for primary surgical debulking?. Seminars in Surgical Oncology. 19(1). 49–53. 23 indexed citations

9.

Vergote, Ignace, Ivo De Wever, Jan Decloedt, et al.. (2000). Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.. PubMed. 27(3 Suppl 7). 31–6. 73 indexed citations

10.

Vergote, Ignace, Ivo De Wever, Wiebren Tjalma, et al.. (2000). Interval debulking surgery: An alternative for primary surgical debulking?. Seminars in Surgical Oncology. 19(1). 49–53. 3 indexed citations

11.

Decloedt, Jan & Ignace Vergote. (1999). Laparoscopy in gynaecologic oncology: a review. Critical Reviews in Oncology/Hematology. 31(1). 15–26. 6 indexed citations

12.

Decloedt, Jan & David Fenton. (1999). Outpatient hysteroscopy: indications and hysteroscopic findings in pre‐ and postmenopausal patients. Gynaecological Endoscopy. 8(3). 137–141. 10 indexed citations

13.

Vergote, Ignace, Ivo De Wever, Wiebren Tjalma, et al.. (1998). Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients. Gynecologic Oncology. 71(3). 431–436. 275 indexed citations

14.

Dam, Peter van, et al.. (1997). Diagnostic laparoscopy to assess operability of advanced ovarian cancer: a feasibility study. 259–266. 3 indexed citations

15.

Decloedt, Jan, Patrick Berteloot, & Ignace Vergote. (1997). The Feasibility of Open Laparoscopy in Gynecologic–Oncologic Patients. Gynecologic Oncology. 66(1). 138–140. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact